Roberto Mignone and Bridger Management’s Portfolio and New Stock Picks

Roberto Mignone’s Bridger Management keeps their returns extremely secret. They do extensive analysis and follow a long/short strategy. Wall Street analysts usually don’t do in-depth analysis of companies. They just talk to the management and their reports are strongly influenced by managements’ statements. Roberto Mignone knows information drives stock prices. One way of having an information advantage is using inside information. This is of course illegal. Another way of having an information advantage is doing the legwork and digging deep by visiting companies, attending trade shows, and talking to journalists and competitors. Recent insider trading arrests show that aggressive forms like these might also be considered illegal.

BRIDGER MANAGEMENT

Katherine Burton profiled Roberto Mignone in her book “Hedge Hunters”. She explains Mignone’s strategy as follow:

“Mignone’s core positions include roughly thirty long positions, which are each limited to 5 percent of the portfolio initially and never get larger than 10 percent. He has about sixty core short positions, each no bigger than 2 percent at the start. He never allows them to grow bigger than 4 percent. Overall, the gross exposure is 150 to 200 percent, meaning the value of the long and short positions adds up to 1.5 to 2 times the net assets in the fund. The net exposure is between 20 and 60 percent.”

Roberto Mignone graduated from Harvard Business School and joined John Griffin at Blue Ridge Capital. Right before his 29th birthday in July 2000, he launched Bridger Management which now manages about $2 Billion. He charges a 1.5 percent management fee and 20 percent incentive fee. He believes fund size is a drag on the performance of a long/short fund manager, so he has no desire to run a much bigger fund than what he is currently running.

Roberto Mignone noticed a trend among hedge fund holdings. There are favored shorts for hedge funds where several hedge funds pile on the same short position. He says hedge funds recently started to pile on to the same long positions as well. He thinks analysts sharing ideas causes herd like behavior of investing in 50-100 stocks, so Mignone prefers to act independently. His top 15 positions at the end of September were:

Name of the Security Value (x1000) Change in Number of Shares
UNITEDHEALTH GROUP (UNH) 106208 -23%
WASTE CONNECTIONS INC (WCN) 95488 -2%
IESI-BFC LTD (BIN) 75354 -7%
CAREFUSION CORP (CFN) 68310 272%
PFIZER INC (PFE) 65160 0%
POPULAR INC (BPOP) 64258 0%
MORGAN STANLEY (MS) 61421 0%
GENPACT LTD (G) 57849 -34%
CENTENE CORP (CNC) 56262 0%
HYATT HOTELS CORP (H) 56085 0%
PALL CORP (PLL) 54394 6%
CARDINAL HEALTH INC (CAH) 52864 13%
HERTZ GLOBAL HOLDINGS (HTZ) 46861 -12%
EXPEDIA INC (EXPE) 45168 New
BOSTON SCIENTIFIC CORP (BSX) 44749 -10%

Mignone’s top position United Health is also one of the top positions in David Tepper’s portfolio. Daniel Loeb added Carefusion to his portfolio during the third quarter. Lee Ainslee’s Maverick Capital has $366 Million worth of Pfizer  and $330 Million of Expedia shares. David Einhorn has nearly $400 Million of Pfizer. Chase Coleman’s Tiger Management increased its position in Genpact (G) and added brand new Green Dot (GDOT) and Amazon (AMZN) positions. There might be some information flow between these two Tiger cubs.

It is clear that Roberto Mignone likes the waste management business though he is slightly reducing his positions in WCN and BIN. His biggest new position is Expedia  (EXPE). Other new positions are Allscripts Healthcare Solutions, Inc. (MDRX), National CineMedia, Inc. (NCMI) (almost new), Activision Blizzard, Inc. (ATVI), Amazon.com (AMZN), Dollar Thrifty Automotive Group Inc. (DTG), SolarWinds, Inc. (SWI), Stratasys Inc. (SSYS), Green Dot Corporation (GDOT), Acorda Therapeutics, Inc. (ACOR).

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!